skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 886  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Pharmacoeconomics remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Productivity Costs in Economic Evaluations: Past, Present, Future
Material Type:
Article
Add to My Research

Productivity Costs in Economic Evaluations: Past, Present, Future

PharmacoEconomics, 2013-07, Vol.31 (7), p.537-549 [Peer Reviewed Journal]

Springer International Publishing Switzerland 2013 ;2014 INIST-CNRS ;COPYRIGHT 2013 Springer ;Copyright Wolters Kluwer Health Adis International Jul 2013 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-013-0056-3 ;PMID: 23620213

Full text available

2
Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User’s Guide
Material Type:
Article
Add to My Research

Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User’s Guide

PharmacoEconomics, 2008, Vol.26 (8), p.661-677 [Peer Reviewed Journal]

Adis Data Information BV 2008 ;2008 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826080-00004 ;PMID: 18620460

Full text available

3
A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)
Material Type:
Article
Add to My Research

A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)

PharmacoEconomics, 2020-11, Vol.38 (11), p.1219-1236 [Peer Reviewed Journal]

The Author(s) 2020 ;COPYRIGHT 2020 Springer ;Copyright Springer Nature B.V. Nov 2020 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-020-00952-0 ;PMID: 32812149

Full text available

4
Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010
Material Type:
Article
Add to My Research

Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010

PharmacoEconomics, 2014-04, Vol.32 (4), p.367-375 [Peer Reviewed Journal]

The Author(s) 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;Copyright Wolters Kluwer Health Adis International Apr 2014 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0136-z ;PMID: 24477679

Full text available

5
Comment on Keeney et al.'s "Delphi Analysis of Relevant Comparators in a Cost‑Effectiveness Model of Prostate Cancer Screening"/Response
Material Type:
Article
Add to My Research

Comment on Keeney et al.'s "Delphi Analysis of Relevant Comparators in a Cost‑Effectiveness Model of Prostate Cancer Screening"/Response

PharmacoEconomics, 2021-08, Vol.39 (8), p.965-970 [Peer Reviewed Journal]

Copyright Springer Nature B.V. Aug 2021 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-021-01061-2

Full text available

6
How to Estimate Productivity Costs in Economic Evaluations
Material Type:
Article
Add to My Research

How to Estimate Productivity Costs in Economic Evaluations

PharmacoEconomics, 2014-04, Vol.32 (4), p.335-344 [Peer Reviewed Journal]

Springer International Publishing Switzerland 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;Copyright Wolters Kluwer Health Adis International Apr 2014 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0132-3 ;PMID: 24504850

Full text available

7
Economic Implications of Endometriosis: A Review
Material Type:
Article
Add to My Research

Economic Implications of Endometriosis: A Review

PharmacoEconomics, 2022-12, Vol.40 (12), p.1143-1158 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. ;COPYRIGHT 2022 Springer ;Copyright Springer Nature B.V. Dec 2022 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-022-01211-0 ;PMID: 36344867

Full text available

8
Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018
Material Type:
Article
Add to My Research

Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018

PharmacoEconomics, 2020-10, Vol.38 (10), p.1135-1145 [Peer Reviewed Journal]

The Author(s) 2020. corrected publication 2020 ;COPYRIGHT 2020 Springer ;Copyright Springer Nature B.V. Oct 2020 ;The Author(s) 2020, corrected publication 2020 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-020-00942-2 ;PMID: 32696192

Full text available

9
Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward
Material Type:
Article
Add to My Research

Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward

PharmacoEconomics, 2023-07, Vol.41 (7), p.787-802 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-022-01231-w

Digital Resources/Online E-Resources

10
A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
Material Type:
Article
Add to My Research

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials

PharmacoEconomics, 2014-12, Vol.32 (12), p.1157-1170 [Peer Reviewed Journal]

The Author(s) 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;Copyright Springer Science & Business Media Dec 2014 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0193-3 ;PMID: 25069632

Full text available

11
Costeffectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement
Material Type:
Article
Add to My Research

Costeffectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement

PharmacoEconomics, 2023-02, Vol.41 (2), p.175-186 [Peer Reviewed Journal]

Copyright Springer Nature B.V. Feb 2023 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-022-01188-w

Full text available

12
Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic Review
Material Type:
Article
Add to My Research

Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic Review

PharmacoEconomics, 2018-10, Vol.36 (10), p.1165-1200 [Peer Reviewed Journal]

Springer International Publishing AG, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Copyright Springer Nature B.V. Oct 2018 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-018-0668-8 ;PMID: 29869050

Full text available

13
The Cost‑Effectiveness of Lorlatinib Versus Chemotherapy as a Secondor Third‑Line Treatment in Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑small‑cell Lung Cancer in Sweden
Material Type:
Article
Add to My Research

The Cost‑Effectiveness of Lorlatinib Versus Chemotherapy as a Secondor Third‑Line Treatment in Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑small‑cell Lung Cancer in Sweden

PharmacoEconomics, 2021-08, Vol.39 (8), p.941-952 [Peer Reviewed Journal]

Copyright Springer Nature B.V. Aug 2021 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-021-01015-8

Full text available

14
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment
Material Type:
Article
Add to My Research

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment

PharmacoEconomics, 2021-11, Vol.39 (11), p.1243-1269 [Peer Reviewed Journal]

The Author(s) 2021. corrected publication 2021 ;2021. The Author(s). ;COPYRIGHT 2021 Springer ;Copyright Springer Nature B.V. Nov 2021 ;The Author(s) 2021, corrected publication 2021 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-021-01065-y ;PMID: 34368939

Full text available

15
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System
Material Type:
Article
Add to My Research

Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System

PharmacoEconomics, 2018-02, Vol.36 (2), p.239-252 [Peer Reviewed Journal]

Springer International Publishing AG 2017 ;COPYRIGHT 2018 Springer ;Copyright Springer Nature B.V. Feb 2018 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-017-0585-2 ;PMID: 29273843

Full text available

16
Calculating and Interpreting ICERs and Net Benefit
Material Type:
Article
Add to My Research

Calculating and Interpreting ICERs and Net Benefit

PharmacoEconomics, 2020-08, Vol.38 (8), p.785-807 [Peer Reviewed Journal]

Springer Nature Switzerland AG 2020 ;COPYRIGHT 2020 Springer ;Copyright Springer Nature B.V. Aug 2020 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-020-00914-6 ;PMID: 32390067

Full text available

17
Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
Material Type:
Article
Add to My Research

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice

PharmacoEconomics, 2015-12, Vol.33 (12), p.1255-1268 [Peer Reviewed Journal]

The Author(s) 2015 ;COPYRIGHT 2015 Springer ;Copyright Springer Science & Business Media Dec 2015 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-015-0309-4 ;PMID: 26105525

Full text available

18
Cost-Effectiveness Thresholds: the Past, the Present and the Future
Material Type:
Article
Add to My Research

Cost-Effectiveness Thresholds: the Past, the Present and the Future

PharmacoEconomics, 2018-05, Vol.36 (5), p.509-522 [Peer Reviewed Journal]

Springer International Publishing AG, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Copyright Springer Nature B.V. May 2018 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-017-0606-1 ;PMID: 29427072

Full text available

19
Erratum
Material Type:
Article
Add to My Research

Erratum

PharmacoEconomics, 2011-12, Vol.29 (12), p.1014 [Peer Reviewed Journal]

Copyright Wolters Kluwer Health Adis International Dec 2011 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11598620-000000000-00000

Full text available

20
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Material Type:
Article
Add to My Research

An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis

PharmacoEconomics, 2021-02, Vol.39 (2), p.181-209 [Peer Reviewed Journal]

The Author(s) 2020 ;COPYRIGHT 2021 Springer ;Copyright Springer Nature B.V. Feb 2021 ;ISSN: 1170-7690 ;ISSN: 1179-2027 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-020-00965-9 ;PMID: 33026634

Full text available

Results 1 - 20 of 886  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2010  (97)
  2. 2010 To 2012  (149)
  3. 2013 To 2015  (170)
  4. 2016 To 2019  (272)
  5. After 2019  (199)
  6. More options open sub menu

Language 

  1. Japanese  (41)
  2. Norwegian  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait